Literature DB >> 9179770

Experimental CVB3-induced chronic myocarditis in two murine strains: evidence of interrelationships between virus replication and myocardial damage in persistent cardiac infection.

L Andréoletti1, D Hober, P Becquart, S Belaich, M C Copin, V Lambert, P Wattré.   

Abstract

In order to analyse the relationships between enteroviral replication and the myocardial damage at the onset of chronic cardiac infection, 2 mouse strains with different degrees of immunological competence (NMRI nu/nu, DBA/2) were infected by a myocarditic Coxsackie virus B3 (CVB3-M1) variant. At 31 days post-inoculation, plaque-forming assay, polymerase chain reaction (RT-PCR), and immunohistochemistry were carried out for detecting viruses and viral components in the myocardium. The virological findings were related to histopathological changes in the myocardium as well to the dilatation of both cardiac ventricles. Chronic myocardial lesions characterized by large fibrosis areas and interstitial inflammatory infiltrates were detected together with cardiomegalia in 52.6% (10/19) of athymic mice and in 9% (2/22) of euthymic mice. Viral replication foci were located and were found only in myocarditic cells adjacent to myocardial inflammatory lesions by immunostaining myocardial tissue sections with anti-serum to VP1 virus capsid protein. Using PCR followed by microwell capture hybridization assay, a large excess of viral positive strand RNA over negative strand was semiquantified in heart tissue from mice with chronic myocarditis, whereas approximately equal amounts of plus and minus strand RNA were detected in cases of persistent cardiac infection without chronic myocardial injuries. These findings provide evidence of the major role of viral replication in the pathogenesis of chronic murine CVB3-induced cardiomyopathy. The results indicate that the cardiac persistence of enteroviral RNAs can be observed without chronic cardiomyopathy, which could be explained by a defective viral positive RNA replication.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9179770     DOI: 10.1002/(sici)1096-9071(199706)52:2<206::aid-jmv15>3.0.co;2-i

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  12 in total

1.  Coxsackievirus B1 infections are associated with the initiation of insulin-driven autoimmunity that progresses to type 1 diabetes.

Authors:  Amir-Babak Sioofy-Khojine; Jussi Lehtonen; Noora Nurminen; Olli H Laitinen; Sami Oikarinen; Heini Huhtala; Outi Pakkanen; Tanja Ruokoranta; Minna M Hankaniemi; Jorma Toppari; Mari Vähä-Mäkilä; Jorma Ilonen; Riitta Veijola; Mikael Knip; Heikki Hyöty
Journal:  Diabetologia       Date:  2018-02-05       Impact factor: 10.122

2.  Molecular mechanisms of coxsackievirus persistence in chronic inflammatory myopathy: viral RNA persists through formation of a double-stranded complex without associated genomic mutations or evolution.

Authors:  P E Tam; R P Messner
Journal:  J Virol       Date:  1999-12       Impact factor: 5.103

3.  beta2-microglobulin-associated regulation of interferon-gamma and virus-specific immunoglobulin G confer resistance against the development of chronic coxsackievirus myocarditis.

Authors:  Karin Klingel; Jens-Jörg Schnorr; Martina Sauter; Gudrun Szalay; Reinhard Kandolf
Journal:  Am J Pathol       Date:  2003-05       Impact factor: 4.307

4.  Coxsackievirus B3 infection activates the unfolded protein response and induces apoptosis through downregulation of p58IPK and activation of CHOP and SREBP1.

Authors:  Huifang M Zhang; Xin Ye; Yue Su; Ji Yuan; Zhen Liu; David A Stein; Decheng Yang
Journal:  J Virol       Date:  2010-06-16       Impact factor: 5.103

5.  Coxsackievirus B3-induced cellular protrusions: structural characteristics and functional competence.

Authors:  Outi Paloheimo; Teemu O Ihalainen; Sisko Tauriainen; Outi Välilehto; Sanna Kirjavainen; Einari A Niskanen; Johanna P Laakkonen; Heikki Hyöty; Maija Vihinen-Ranta
Journal:  J Virol       Date:  2011-04-27       Impact factor: 5.103

6.  Frequent detection of parvovirus B19 genome in the myocardium of adult patients with idiopathic dilated cardiomyopathy.

Authors:  Ulrich Lotze; Renate Egerer; Christiane Tresselt; Brigitte Glück; Gudrun Dannberg; Axel Stelzner; Hans R Figulla
Journal:  Med Microbiol Immunol       Date:  2003-12-20       Impact factor: 3.402

7.  A new monoclonal antibody (Cox mAB 31A2) detects VP1 protein of coxsackievirus B3 with high sensitivity and specificity.

Authors:  Nicole Ettischer-Schmid; Andrea Normann; Martina Sauter; Lisa Kraft; Hubert Kalbacher; Reinhard Kandolf; Bertram Flehmig; Karin Klingel
Journal:  Virchows Arch       Date:  2016-08-27       Impact factor: 4.064

8.  Connective tissue growth factor: a crucial cytokine-mediating cardiac fibrosis in ongoing enterovirus myocarditis.

Authors:  Christine Lang; Martina Sauter; Gudrun Szalay; Giorgia Racchi; Gabriele Grassi; Giuseppe Rainaldi; Alberto Mercatanti; Florian Lang; Reinhard Kandolf; Karin Klingel
Journal:  J Mol Med (Berl)       Date:  2007-09-11       Impact factor: 4.599

9.  Enterovirus infections: Pivoting role of the adaptive immune response.

Authors:  Shubhada Bopegamage
Journal:  Virulence       Date:  2016-04-08       Impact factor: 5.882

Review 10.  Chronic viral infections in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS).

Authors:  Santa Rasa; Zaiga Nora-Krukle; Nina Henning; Eva Eliassen; Evelina Shikova; Thomas Harrer; Carmen Scheibenbogen; Modra Murovska; Bhupesh K Prusty
Journal:  J Transl Med       Date:  2018-10-01       Impact factor: 5.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.